Send us Feedback

Cleveland BioLabs (CBLI)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
Cleveland Biolabs, Inc. (CBLI) Posts Q1 Loss of 22c/Share
StreetInsider.com  May 9  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Cleveland+Biolabs%2C+Inc.+%28CBLI%29+Posts+Q1+Loss+of+22cShare/8320619.html for the full story.
Zacks Bull and Bear of the Day Highlights: Private Bancorp, Pan American Silver, AVEO Pharmaceuticals, Astellas Pharma and Cleveland BioLabs
Cloud Computing  May 6  Comment 
CHICAGO , May 6, 2013 /PRNewswire/ -- Zacks Equity Research highlights Private Bancorp (Nasdaq:PVTB) as the Bull of the Day and Pan American Silver (Nasdaq:PAAS) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on...
Cleveland BioLabs, Incuron Announce Notice of Allowance from FDA to Commence Clinical Testing of CBL0137
Benzinga  Apr 2  Comment 
Cleveland BioLabs (NASDAQ: CBLI) and Incuron, LLC, a joint venture between the Company and Bioprocess Capital Ventures, today announced the receipt of a Notice of Allowance from the U.S. Food and Drug Administration (FDA) for an Investigational...
Cleveland BioLabs (CBLI), Incuron Receive FDA Approval for CBL0137 IND
StreetInsider.com  Apr 2  Comment 
StreetInsider.com Pre-Open Movers 03/21: (ITMN) (CBLI) (PERY) Higher; (ORCL) (TUMI) (GES) Lower (more...)
StreetInsider.com  Mar 21  Comment 
InterMune Inc. (NASDAQ: ITMN) 10% HIGHER; Esbrie receives positive final appraisal Determination from NICE for Idiopathic Pulmonary Fibrosis (IPF) Cleveland BioLabs (NASDAQ: CBLI) 9% HIGHER; Cantor Fitzgerald initiates coverage on with a Buy. PT...
UPDATE: Cantor Fitzgerald Initiates Cleveland BioLabs at Buy on Improving Valuation
Benzinga  Mar 21  Comment 
In a report published by Cantor Fitzgerald, analyst Mara Goldstein initiated coverage on Cleveland BioLabs (NASDAQ: CBLI) with a Buy rating and $4 price target. Cantor Fitzgerald reported that, “Cleveland BioLabs is a development stage...
Streetinsider.com After-Hours Movers 3/20: (CBLI) (JCP) Higher; (TLYS) (TUMI) (ORCL) Lower (more...)
StreetInsider.com  Mar 20  Comment 
Tillys (NYSE: TLYS) 10% LOWER; reported Q4 EPS of $0.32, $0.02 better than the analyst estimate of $0.30. Revenue for the quarter came in at $140.8 million versus the consensus estimate of $141.1 million. Comparable store sales for the...
Cleveland Biolabs, Inc. (CBLI) Swings to Q4 Profit
StreetInsider.com  Mar 14  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Cleveland+Biolabs%2C+Inc.+%28CBLI%29+Swings+to+Q4+Profit/8184122.html for the full story.
Benzinga's Small Cap Movers for Monday February 4, 2013
Benzinga  Feb 4  Comment 
Below are highlights from Benzinga's daily coverage of small cap securities making big moves: Cleveland BioLabs Shares of Cleveland BioLabs (NASDAQ: CBLI), the Buffalo, NY biotechnology company, rose 12.5% Monday on 4 times average...
UPDATE: Oppenheimer Initiates Cleveland BioLabs at Outperform; A Unique Opportunity
Benzinga  Dec 6  Comment 
Oppenheimer initiated coverage on Cleveland BioLabs (NASDAQ: CBLI) with an Outperform rating and a $3 price target. Oppenheimer commented, "Biodefense drug development has a unique risk/reward risk profile. On the positive side, there is...
Benzinga's Top Initiations
Benzinga  Dec 6  Comment 
Analysts at Goldman Sachs initiated coverage on shares of Quiksilver (NYSE: ZQK) with a “neutral” rating. Quiksilver's shares closed at $4.01 yesterday. Quiksilver's trailing-twelve-month operating margin is 3.94%. Brean Capital initiated...




RELATED WIKI ARTICLES

Related Articles

more ▼WIKI ANALYSIS
 
TOP CONTRIBUTORS
Sr. Director
Grant Zeng
www.zacks.com

Founded in 2003, Cleveland BioLabs Inc. (CBLI) is a specialized pharmaceutical company involved in the discovery, development, and commercialization of products for cancer treatment and protection of normal tissues from exposure to radiation and other stresses. The company's proprietary technology platform is based on the ability to suppress or stimulate a basic cell defense mechanism called apoptosis, or programmed cell death. Cleveland's drugs can switch apoptosis on and off by affecting key regulators of cell response to stresses, such as radiation or ischemia.

Cleveland has a collaboration agreement with Cleveland Clinic Foundation to use Cleveland Clinic's research base underlying the company's therapeutic platform strategic research partnership with Roswell Park Cancer Institute to develop its cancer and radioprotectant drug candidates and strategic partnership with ChemBridge Corporation to access a chemical library of 214,000 compounds and jointly manage the development and commercialization of compounds arising from selected projects. The company is headquartered in Buffalo, New York and had 35 employees as of December 31, 2006.




References

Retrieved from "http://www.wikinvest.com/stock/Cleveland_BioLabs_(CBLI)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki